 Matrix Metalloproteinase 13
"Matrix Metalloproteinase 13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide.
| Descriptor ID |
D053509
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.363 D08.811.277.656.300.480.525.700.550 D08.811.277.656.675.374.205.363 D08.811.277.656.675.374.525.700.550
|
| Concept/Terms |
Matrix Metalloproteinase 13- Matrix Metalloproteinase 13
- Metalloproteinase 13, Matrix
- MMP13 Metalloproteinase
- Metalloproteinase, MMP13
- Matrix Metalloproteinase-13
- Metalloproteinase-13, Matrix
- MMP-13 Metalloproteinase
- MMP 13 Metalloproteinase
- Metalloproteinase, MMP-13
- Collagenase 3
- Collagenase-3
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 13".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 13".
This graph shows the total number of publications written about "Matrix Metalloproteinase 13" by people in this website by year, and whether "Matrix Metalloproteinase 13" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 | | 2007 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Matrix Metalloproteinase 13" by people in Profiles.
-
Kc R, Li X, Voigt RM, Ellman MB, Summa KC, Vitaterna MH, Keshavarizian A, Turek FW, Meng QJ, Stein GS, van Wijnen AJ, Chen D, Forsyth CB, Im HJ. Environmental disruption of circadian rhythm predisposes mice to osteoarthritis-like changes in knee joint. J Cell Physiol. 2015 Sep; 230(9):2174-83.
-
Salaün M, Peng J, Hensley HH, Roder N, Flieder DB, Houlle-Crépin S, Abramovici-Roels O, Sabourin JC, Thiberville L, Clapper ML. MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma. PLoS One. 2015; 10(7):e0132960.
-
Fitzgerald JB, Jin M, Chai DH, Siparsky P, Fanning P, Grodzinsky AJ. Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J Biol Chem. 2008 Mar 14; 283(11):6735-43.
-
Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem. 2007 Jun 22; 282(25):18265-75.
-
Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, Flavell RA, Gravallese EM, Oettgen P, Libermann TA, Goldring MB. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem. 2005 Nov 18; 280(46):38544-55.
-
Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A. 2005 Feb 1; 102(5):1454-9.
-
Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, Drissi H, O'Keefe RJ. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res. 2004 Oct 15; 300(1):159-69.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|